DIL Walk Foundation & BioAro Inc.

BioAro is a leading innovator in genomic analysis and precision medicine, aiming to build new opportunities for patients, healthcare and the research sector. BioAro is advancing artificial intelligence technology to leverage its advantages for predicting health crises and developing the most optimal treatment solutions with genomic insights.

As the precision medicine market grows, BioAro aims to be at the forefront of its development with software for real-time genomic analysis, patient motoring, predictive models for health assessment, and AI-integrated systems for record management, uniting all under one integrated ecosystem. This approach optimizes operations and expenses of the healthcare sector while enhancing overall patient care.

BioAro’s mission is to deliver precision care to the people. Our solutions for healthcare and research sectors provide crucial information for understanding the complexity of the human body and microflora ecosystem for optimal and precise patient care and research purposes related to improving treatment strategies.
We believe in and deliver real-time data-driven optimal medical care and explore collaborations in the precision medicine field to make it more accessible for people.

BioAro, in partnership with CardiAI Inc. and DIL Walk Foundation, is excited to announce the largest ABPM screening campaign in North America! Taking place in Alberta, this groundbreaking initiative teams up with nurse practitioners to empower patients to become the "CEO of their own health." Our goal is to screen 100,000 people, helping them take control of their health and well-being.